Registry for Acute Decompensated Heart Failure Patients Admitted to the ER
NCT ID: NCT00364325
Last Updated: 2010-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18920 participants
OBSERVATIONAL
2004-07-31
2006-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Acute Decompensated Heart Failure Patients
NCT00366639
Longitudinal Registry for Advanced Heart Failure Patients
NCT00364416
Heart Failure Registry
NCT00530426
DR REGISTRY: Prospective Observational Study of ADHF Patients With Insufficient Response to Diuretics
NCT04877652
Adherence to Medication in Patients With Acute Decompensated Heart Failure
NCT06459115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
001
Acute Decompensated Heart Failure
Standard of Care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acute Decompensated Heart Failure
Standard of Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received or is eligible to receive a principal ED and/or hospital discharge diagnosis of ADHF
* ADHF is present as determined clinically by the patient care team and as documented in the DRG (Diagnosis-related Group) or APC (Ambulatory Payment Classifications) codes, and ADHF is the focus of treatment
* If required by site IRB/IEC patient (or legally acceptable representative) must be able to give informed consent for participation
Exclusion Criteria
* Patient was not treated in ED during this episode of care
* Participation in any clinical trial that precludes use of a Disease Management Program (specific component of the disease are managed in an integrated manner by a team of physicians, pharmacists, nurses and communication experts)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scios, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scios
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scios, Inc. Clinical Trial
Role: STUDY_DIRECTOR
Scios, Inc.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR005215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.